Novartis Ag Adr Stock Widgets and Gadgets
| NVS Stock | USD 98.35 1.07 1.10% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- NVS Novartis AG ADR
- Latest Why Novartis Stock Topped the Market on Tuesday
- NVS 98.35 1.07
- Low 97.41
- High 98.55
- Volume 2.5 M
- Alpha -0.16
- Beta 0.64
- Return On Equity 0.2
- Return On Asset 0.0865
- Profit Margin 0.32 %
- Operating Margin 0.31 %
- Current Valuation 216.21 B
- Shares Outstanding 2.04 B
- Shares Owned By Institutions 6.92 %
- Number Of Shares Shorted 4.21 M
- Price To Earning 9.22 X
- Price To Book 4.10 X
- Price To Sales 4.14 X
- Revenue 46.66 B
- Gross Profit 36.74 B
- EBITDA 18.47 B
- Net Income 8.57 B
- Cash And Equivalents 4.64 B
- Cash Per Share 8.84 X
- Total Debt 26.35 B
- Debt To Equity 0.47 %
- Current Ratio 1.31 X
- Book Value Per Share 19.45 X
- Cash Flow From Operations 14.46 B
- Short Ratio 2.77 X
- Earnings Per Share 4.10 X
- Price To Earnings To Growth 5.09 X
- Target Price 113.07
- Number Of Employees 76.06 K
- Beta 0.48
- Market Capitalization 198.95 B
- Total Asset 99.94 B
- Retained Earnings 49.65 B
- Working Capital 4.09 B
- Current Asset 22.84 B
- Current Liabilities 23.71 B
- Annual Yield 0.04 %
- Five Year Return 3.53 %
- Net Asset 99.94 B
- Last Dividend Paid 3.92
- Accumulation Distribution 28606.8
- Daily Balance Of Power 0.9386
- Rate Of Daily Change 1.01
- Day Median Price 97.98
- Day Typical Price 98.1
- Price Action Indicator 0.9
- Period Momentum Indicator 1.07
- Relative Strength Index 51.66
Market Snapshot Widget Example
DAX Index Germany | 18,089 0.27 | |
Taiwan Weighted Taiwan | 20,132 2.72 | |
PSI 20 Stock Portugal | 6,530 0.95 | |
CROBEX Croatia | 2,786 0.05 | |
Budapest SE Hungary | 66,377 0.66 | |
IDX 30 Jakarta Indonesia | 472.42 0.44 | |
ISEQ 20 Price Ireland | 1,652 0.95 | |
NYSE Comp USA | 17,758 0.19 | |
Tel Aviv 35 Israel | 1,938 1.13 | |
Coreshares Index Tracker South Afric | 1,056 1.44 | |
IPC MEXICO Mexico | 56,464 0.3 | |
KL Technology Malaysia | 64.16 1.55 | |
IBEX 35 Index Spain | 11,028 0.43 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,580 0.02 | |
SPASX Dividend Opportunities Australia | 1,657 0.08 | |
HNX 30 Vietnam | 481.21 2.05 | |
Bucharest BET-NG Romania | 1,202 0.1 | |
AMS Small Cap Netherlands | 1,189 1.29 | |
Oslo Exchange Mutual Norway | 1,304 1.04 | |
BEL Small Belgium | 9,020 0.03 | |
RTSI Index Russia | 1,172 0.66 | |
Basic Materials Brazil | 5,814 0.49 | |
Swiss Leader Price Switzerland | 1,857 0.69 | |
Fondo Mutuo ETF Chile | 1,416 0.34 | |
Athens General Comp Greece | 1,449 0.06 | |
Stock Exchange Of Thailand | 1,361 0.27 | |
PX Prague Stock Czech Repub | 1,557 0.49 | |
THE PHILIPPINE STOCK Philippines | 6,573 1.01 | |
WIG 30 Poland | 3,051 0.89 | |
BIST Electricity Turkey | 592.91 0.41 |
Investing Ideas
In addition to having Novartis in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Novartis
Compare Novartis To Peers
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novartis AG ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Novartis Stock analysis
When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is Novartis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novartis. If investors know Novartis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novartis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.215 | Dividend Share 3.919 | Earnings Share 4.1 | Revenue Per Share 23.168 | Quarterly Revenue Growth 0.097 |
The market value of Novartis AG ADR is measured differently than its book value, which is the value of Novartis that is recorded on the company's balance sheet. Investors also form their own opinion of Novartis' value that differs from its market value or its book value, called intrinsic value, which is Novartis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novartis' market value can be influenced by many factors that don't directly affect Novartis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novartis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Novartis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novartis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.